177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Clinical trial NCT06395402 · RECRUITING

Trial details

NCT number: NCT06395402
Sponsor: University of Iowa
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Neuroendocrine Tumor Grade 1 Neuroendocrine Tumor Grade 2

Start date: 2024-05-03
Primary completion: 2029-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.